Cell & Gene: The Podcast

Cell & Gene: The Podcast

The Promise of AAV Gene Therapy with REGENXBIO's Ken Mills

Nov 9, 2023 · 28m

✨ AI Summary

REGENXBIO discusses AAV gene therapy progress and scalability.
Updates on the Affinity Duchenne trial for DMD.
Focus on consistent yield and product purity in manufacturing.

Guests on This Episode

researcher · 1 podcast appearance

More from Cell & Gene: The Podcast

Advancing Cell Therapy Toward a Functional Cure for T1D With Forthcoming BetaNova's Jonathan Rigby and Will Rust, Ph.D.

Oct 8, 2026 · 24m

Structuring CGT Deals for the Long Term with Troutman Pepper Locke's EA Weeks, J.D., Ph.D.

Sep 24, 2026 · 27m

Shaping Drug Development by Starting with the Disease with Roche's Sylke Poehling, Ph.D.

Sep 10, 2026 · 18m

Why Autoimmune CAR T Needs a New Patient-Centered Playbook with Dr. Panteli Theocharous

Aug 27, 2026 · 40m

View all episodes →